BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33669101)

  • 1. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
    Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.
    Rabkin E; Aikawa M; Stone JR; Fukumoto Y; Libby P; Schoen FJ
    Circulation; 2001 Nov; 104(21):2525-32. PubMed ID: 11714645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
    Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
    PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.
    Shapero K; Wylie-Sears J; Levine RA; Mayer JE; Bischoff J
    J Mol Cell Cardiol; 2015 Mar; 80():175-85. PubMed ID: 25633835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
    Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
    J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
    Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
    Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
    Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
    Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture and characterisation of canine mitral valve interstitial and endothelial cells.
    Liu MM; Flanagan TC; Lu CC; French AT; Argyle DJ; Corcoran BM
    Vet J; 2015 Apr; 204(1):32-9. PubMed ID: 25747697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
    Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
    Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study.
    Tiveron MG; Pomerantzeff PMA; de Lourdes Higuchi M; Reis MM; de Jesus Pereira J; Kawakami JT; Ikegami RN; de Almeida Brandao CM; Jatene FB
    BMC Infect Dis; 2017 Apr; 17(1):297. PubMed ID: 28431520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
    Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
    Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
    Dye BK; Butler C; Lincoln J
    J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis.
    Flanagan TC; Black A; O'Brien M; Smith TJ; Pandit AS
    Cells Tissues Organs; 2006; 183(1):12-23. PubMed ID: 16974091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves.
    Ho YC; Geng X; O'Donnell A; Ibarrola J; Fernandez-Celis A; Varshney R; Subramani K; Azartash-Namin ZJ; Kim J; Silasi R; Wylie-Sears J; Alvandi Z; Chen L; Cha B; Chen H; Xia L; Zhou B; Lupu F; Burkhart HM; Aikawa E; Olson LE; Ahamed J; López-Andrés N; Bischoff J; Yutzey KE; Srinivasan RS
    Circ Res; 2023 Sep; 133(6):463-480. PubMed ID: 37555328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
    Han RI; Clark CH; Black A; French A; Culshaw GJ; Kempson SA; Corcoran BM
    Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves.
    Gupta V; Barzilla JE; Mendez JS; Stephens EH; Lee EL; Collard CD; Laucirica R; Weigel PH; Grande-Allen KJ
    Cardiovasc Pathol; 2009; 18(4):191-7. PubMed ID: 18621549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition.
    Songia P; Branchetti E; Parolari A; Myasoedova V; Ferrari G; Alamanni F; Tremoli E; Poggio P
    J Mol Cell Cardiol; 2016 Sep; 98():48-57. PubMed ID: 27338002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
    Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
    J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.